4.7 Article

Anastrozole-mediated modulation of mitochondrial activity by inhibition of mitochondrial permeability transition pore opening: an initial perspective

出版社

TAYLOR & FRANCIS INC
DOI: 10.1080/07391102.2023.2176927

关键词

Anastrozole; mitochondrial permeability transition pore; mitochondrial disorders; molecular docking; MD simulation; protein targets; binding sites; docking complexes; structural modelling

向作者/读者索取更多资源

The mitochondrial permeability transition pore (mtPTP) is essential for altering mitochondria's structure and function. Cyclophilin D (CypD), a mitochondrial protein, plays a role in regulating mtPTP function, making it a potential target for mitochondrial therapeutic studies. This study explored the impact of anastrozole on mtPTP functioning using docking, molecular dynamics, and network-guided studies. The results showed that anastrozole outperformed cyclosporine in inhibiting mtPTP, inducing membrane depolarization, reducing mitochondrial swelling and superoxide generation, and increasing ATP levels. These findings suggest that anastrozole could serve as a therapeutic agent for mitochondrial disorders by regulating mtPTP activity.
The mitochondrial permeability transition pore (mtPTP) plays a vital role in altering the structure and function of mitochondria. Cyclophilin D (CypD) is a mitochondrial protein that regulates mtPTP function and a known drug target for therapeutic studies involving mitochondria. While the effect of aromatase inhibition on the mtPTP has been studied previously, the effect of anastrozole on the mtPTP has not been completely elucidated. The role of anastrozole in modulating the mtPTP was evaluated by docking, molecular dynamics and network-guided studies using human CypD data. The peripheral blood mononuclear cells (PBMCs) of patients with mitochondrial disorders and healthy controls were treated with anastrozole and evaluated for mitochondrial permeability transition pore (mtPTP) function and apoptosis using a flow cytometer. Spectrophotometry was employed for estimating total ATP levels. The anastrozole-CypD complex is more stable than cyclosporin A (CsA)-CypD. Anastrozole performed better than cyclosporine in inhibiting mtPTP. Additional effects included inducing mitochondrial membrane depolarization and a reduction in mitochondrial swelling and superoxide generation, intrinsic caspase-3 activity and cellular apoptosis, along with an increase in ATP levels. Anastrozole may serve as a potential therapeutic agent for mitochondrial disorders and ameliorate the clinical phenotype by regulating the activity of mtPTP. However, further studies are required to substantiate our preliminary findings.Communicated by Ramaswamy H. Sarma

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据